Patents by Inventor Michael Ernst Trautmann

Michael Ernst Trautmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chronic treatment regimen using glucagon-like insulinotropic peptides
    Patent number: 7989585
    Abstract: The present invention encompasses a method of treating a disease by maintaining chronic steady state serum levels of a GLP-1 compound within a specified range.
    Type: Grant
    Filed: August 10, 2007
    Date of Patent: August 2, 2011
    Assignee: Eli Lilly and Company
    Inventors: Steven Witt Dodd, Kenneth Francis Mace, Michael Ernst Trautmann
  • CHRONIC TREATMENT REGIMEN USING GLUCAGON-LIKE INSULINOTROPIC PEPTIDES
    Publication number: 20090186813
    Abstract: The present invention encompasses a method of treating a disease by maintaining chronic steady state serum levels of a GLP-1 compound within a specified range.
    Type: Application
    Filed: August 10, 2007
    Publication date: July 23, 2009
    Inventors: Steven Witt Dodd, Kenneth Francis Mace, Michael Ernst Trautmann
  • Chronic treatment regimen using glucagon-like insulinotropic peptides
    Patent number: 7259233
    Abstract: The present invention encompasses a method of treating a disease by maintaining chronic steady state serum levels of a GLP-1 compound within a specified range.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: August 21, 2007
    Assignee: Eli Lilly and Company
    Inventors: Steven Witt Dodd, Kenneth Francis Mace, Michael Ernst Trautmann
  • Biphasic mixtures of GLP-1 and insulin
    Patent number: 7179788
    Abstract: The present invention encompasses pharmaceutical formulations comprising a biphasic mixture which comprises a glucagon like peptide (GLP-1) compound in a solid phase and an insulin in a solution phase.
    Type: Grant
    Filed: October 7, 2002
    Date of Patent: February 20, 2007
    Assignee: Eli Lilly and Company
    Inventors: Michael Rosario DeFelippis, Richard Dennis DiMarchi, Kingman Ng, Michael Ernst Trautmann
  • Biphasic mixtures of glp-1 and insulin
    Publication number: 20040254107
    Abstract: The present invention encompasses pharmaceutical formulations comprising a biphasic mixture which comprises a glucagon like peptide (GLP-1) compound in a solid phase and an insulin in a solution phase.
    Type: Application
    Filed: March 19, 2004
    Publication date: December 16, 2004
    Inventors: Michael Rosario DeFelippis, Richard Dennis DiMarchi, Kingman Ng, Michael Ernst Trautmann
  • Chronic treatment regimen using glucagon-like insulinotropic peptides
    Publication number: 20040053819
    Abstract: The present invention encompasses a method of treating a disease by maintaining chronic steady state serum levels of a GLP-1 compound within a specified range.
    Type: Application
    Filed: June 10, 2003
    Publication date: March 18, 2004
    Inventors: Steven Witt Dodd, Kenneth Francis Mace, Michael Ernst Trautmann